A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep

Bioelectrochemistry

Volumn 70, Issue 2, 2007, Pages 269-274

  Babiuk, Shawn ^a   Tsang, Cemaine ^a   van Drunen Littel van den Hurk, Sylvia ^a   Babiuk, Lorne A ^a   Griebel, Philip J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

DNA vaccine; Electroporation; HBsAg; Immune memory; Sheep

Indexed keywords

ANIMALS; COST EFFECTIVENESS; DISEASES; DNA; IMMUNIZATION; TITRATION; VACCINES;

DNA VACCINES; ELECTROPORATION; IMMUNE MEMORY; SHEEP;

ANTIBODIES;

DNA VACCINE; HEPATITIS B SURFACE ANTIGEN; RECOMBINANT HEPATITIS B VACCINE;

ANAMNESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DRUG EFFICACY; ELECTROPORATION; MALE; MEMORY CELL; NONHUMAN; SHEEP; VACCINATION;

ANIMALS; DRUG DELIVERY SYSTEMS; ELECTROPORATION; FEMALE; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; MALE; SHEEP; TRANSFECTION; VACCINATION; VACCINES, DNA;

ANIMALIA; OVIS ARIES;

EID: 33947726702     PISSN: 15675394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bioelechem.2006.10.003     Document Type: Article

References (29)

1. Whalen R.G. DNA vaccines for emerging infectious diseases: what if?. Emerg. Infect. Dis. 2 (1996) 168-175
2. Donnelly J.J., Ulmer J.B., Shiver J.W., and Liu M.A. DNA vaccines. Annu. Rev. Immunol. 15 (1997) 617-648
3. van Drunen Littel-van den Hurk S., Gerdts V., Loehr B.I., Pontarollo R., Rankin R., Uwiera R., and Babiuk L.A. Recent advances in the use of DNA vaccines for the treatment of diseases of farmed animals. Adv. Drug Deliv. Rev. 43 (2000) 13-28
4. MacGregor R.R., Boyer J.D., Ugen K.E., Lacy K.E., Gluckman S.J., Bagarazzi M.L., Chattergoon M.A., Baine Y., Higgins T.J., Ciccarelli R.B., Coney L.R., Ginsberg R.S., and Weiner D.B. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178 (1998) 92-100
5. Chiang Y.-W., Jennen C.M., Holt T.M., et al. Demonstration of efficacy of a West Nile DNA vaccine in foals. AAEP Proceedings (2005) 183-194
6. Gregoriadis G., Saffie R., and de Souza J.B. Liposome-mediated DNA vaccination. FEBS Lett. 402 (1997) 107-110
7. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., and Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl. Acad. Sci. U. S. A. 90 (1994) 11478-11482
8. Dupuis M., Denis-Mize K., Woo C., Goldbeck C., Selby M.J., Chen M., Otten G.R., Ulmer J.B., Donnelly J.J., Ott G., and McDonald D.M. Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice. J. Immunol. 165 (2000) 2850-2858
9. Mir L.M., Moller P.H., Andre F., and Gehl J. Electric pulse-mediated gene delivery to various animal tissues. Adv. Genet. 54 (2005) 83-114
10. Zaharoff D.A., Barr R.C., Li C.Y., and Yuan F. Electromobility of plasmid DNA in tumor tissues during electric field-mediated gene delivery. Gene Ther. 9 (2002) 1286-1290
11. Widera G., Austin M., Rabussay D., Goldbeck C., Barnett S.W., Chen M., Leung L., Otten G.R., Thudium K., Selby M.J., and Ulmer J.B. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164 (2000) 4635-4640
12. Babiuk S., Baca-Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., and Babiuk L.A. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20 (2002) 3399-3408
13. Scheerlinck J.P., Karlis J., Tjelle T.E., Presidente P.J., Mathiesen I., and Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22 (2004) 1820-1825
14. Babiuk S., Baca-Estrada M., Foldvari M., Middleton D., Rabussay D., Widera G., and Babiuk L.A. Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines. J. Biotechnol. 110 (2004) 1-10
15. McMahon J.M., Signori E., Wells K.E., Fazio V.M., and Wells D.J. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase - increased expression with reduced muscle damage. Gene Ther. 8 (2001) 1264-1270
16. Pazmany T., Murphy S.P., Gollnick S.O., Brooks S.P., and Tomasi T.B. Activation of multiple transcription factors and fos and jun gene family expression in cells exposed to a single electric pulse. Exp. Cell Res. 221 (1995) 103-110
17. Chattergoon M.A., Saulino V., Shames J.P., Stein J., Montaner L.J., and Weiner D.B. Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice. Vaccine 22 (2004) 1744-1750
18. Gerdts V., Snider M., Brownlie R., Babiuk L.A., and Griebel P.J. Oral DNA vaccination in utero induces mucosal immunity and immune memory in the neonate. J. Immunol. 168 (2002) 1877-1885
19. Fazio V.M., Ria F., Franco E., Rosati P., Cannelli G., Signori E., Parrella P., Zaratti L., Iannace E., Monego G., Blogna S., Fioretti D., Iurescia S., Filippetti R., and Rinaldi M. Immune response at birth, long-term immune memory and 2 years follow-up after in-utero anti-HBV DNA immunization. Gene Ther. 11 (2004) 544-551
20. Weeratna R., Brazolot-Millan C.L., Krieg A.M., and Davis H. Reduction of antigen expression from DNA vaccines by co-administrated oligonucleotides. Antisense Nucleic Acid Drug Dev. 8 (1998) 351-356
21. Rankin R., Pontarollo R., Ioannou X., Krieg A.R., Hecker R., Babiuk L.A., and van Drunen Littel-van den Hurk S. CpG motif identification for veterinary and laboratory species demonstrates that sequence recognition is highly conserved. Antisense Nucleic Acid Drug Dev. 11 (2001) 333-340
22. Burrells C., and Wells P. In vitro stimulation of ovine lymphocytes by various mitogens. Res. Vet. Sci 23 (1977) 84-86
23. West D.J., and Calandra G.B. Vaccine induced immunologic memory for hepatitis B surface antigen: implications for policy on booster vaccination. Vaccine 14 (1996) 1019-1027
24. Aberle J.H., Aberle S.W., Allison S.L., Stiasny K., Ecker M., Mandl C.W., Berger R., and Heinz F.X. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms. J. Immunol. 163 (1999) 6756-6761
25. Fernandez F.M., Conner M.E., Hodgins D.C., Parwani A.V., Crawford S.E., Estes M.K., and Saif L.S. Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine 16 (1998) 507-516
26. Fehr T., Skrastina D., Pumpens P., and Zinkernagel R.M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 9477-9481
27. Abbing A., Blaschke U.K., Grein S., Kretschmar M., Stark C.M., Thies M.S., Walter J., Weigand M., Woith D.C., Hess J., and Reiser C.O. Efficient intracellular delivery of a protein and a low molecular weight substance via recombinant polyomavirus-like particles. J. Biol. Chem. 279 (2004) 27410-27421
28. Allsopp C.E., Plebanski M., Gilbert S., Sinden R.E., Harris S., Frankel G., Dougan G., Hioe C., Nixon D., Paolletti E., Layton G., and Hill A.V. Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol. 26 (1996) 1951-1959
29. Tjelle T.E., Salte R., Mathiesen I., and Kjeken R.A. A novel electroporation device for gene delivery in large animals and humans. Vaccine 24 (2006) 4667-4670